A stent for co-delivering paclitaxel and nitric oxide from abluminal and luminal surfaces: Preparation, surface characterization, and in vitro drug release studiesGALLO, Annemarie; MANI, Gopinath.Applied surface science. 2013, Vol 279, pp 216-232, issn 0169-4332, 17 p.Article

Current Status of Drug-Eluting StentsRABER, Lorenz; WINDECKER, Stephan.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 176-189, issn 1755-5914, 14 p.Article

In-Stent RestenosisKIM, Michael S; DEAN, Larry S.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 190-198, issn 1755-5914, 9 p.Article

Effect of processing methods on drug release profiles of anti-restenotic self-assembled monolayersSTOEBNER, Susan E; MANI, Gopinath.Applied surface science. 2012, Vol 258, Num 12, pp 5061-5072, issn 0169-4332, 12 p.Article

Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent ImplantationFERREIRA-GONZALEZ, Ignacio; MARSAL, Josep R; ALFONSO, Fernando et al.Circulation (New York, N.Y.). 2010, Vol 122, Num 10, pp 1017-1025, issn 0009-7322, 9 p.Article

Novel farnesylthiosalicylate (FTS)-eluting composite structuresKRAITZER, Amir; KLOOG, Yoel; ZILBERMAN, Meital et al.European journal of pharmaceutical sciences. 2009, Vol 37, Num 3-4, pp 351-362, issn 0928-0987, 12 p.Article

Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut appositionTANIGAWA, Jun; BARLIS, Peter; DI MARIO, Carlo et al.EuroIntervention. 2007, Vol 3, Num 1, pp 128-136, issn 1774-024X, 9 p.Article

The clinical outcome of restricting drug-eluting stents to patients at highest risk of restenosisROY, Probal; YAN, Bryan P; BOWYER, Andrea et al.EuroIntervention. 2006, Vol 2, Num 2, pp 238-243, issn 1774-024X, 6 p.Article

Update on drug-eluting stents : as good as it gets?JAIN, Ajay K; MATHUR, Anthony.Clinical medicine. 2007, Vol 7, Num 4, pp 401-404, issn 1470-2118, 4 p.Article

XTENT® Custom NX™ drug eluting stent systemsEVANS, Laura Wilkes; DORAN, Paula; MARCO, Philippe et al.EuroIntervention. 2007, Vol 3, Num 1, pp 158-161, issn 1774-024X, 4 p.Article

Investigation on biological properties of tacrolimus-loaded poly(1,3-trimethylene carbonate) in vitroRUIXIA HOU; LEIGANG WU; JIN WANG et al.Applied surface science. 2010, Vol 256, Num 16, pp 5000-5005, issn 0169-4332, 6 p.Article

Drug-eluting stents for diabetes mellitus: A rush to judgment?FINN, Aloke V; PALACIOS, Igor F; KASTRATI, Adnan et al.Journal of the American College of Cardiology. 2005, Vol 45, Num 4, pp 479-483, issn 0735-1097, 5 p.Article

Drug eluting stents in 2005GERSHLICK, A. H.Heart. Supplement. 2005, Vol 91, Num 3, pp iii24-iii31Article

Current Status of Drug Eluting StentsKIPSHIDZE, Nicholas.Current pharmaceutical design (Print). 2010, Vol 16, Num 36, issn 1381-6128, 96 p.Serial Issue

Les stents coronaires à élution sont-ils dangereux? : Cardiologie = Are drug-eluting stents dangerous ?DE BENEDETTI, Edoardo; URBAN, Philip.Revue médicale suisse. 2007, Vol 3, Num 102, pp 656-658, issn 1660-9379, 3 p.Article

Drug-eluting stents : a critiqueMELIKIAN, N; WIJNS, W.Heart (London 1996). 2008, Vol 94, Num 2, pp 145-152, issn 1355-6037, 8 p.Article

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsMAURI, Laura; KEREIAKES, Dean J; HOLMES, David R et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2155-2166, issn 0028-4793, 12 p.Article

AXXESS™ Biolimus A9® eluting bifurcation stent systemVERHEYE, Stefan; TRAUTHEN, Brett.EuroIntervention. 2007, Vol 2, Num 4, pp 506-508, issn 1774-024X, 3 p.Article

Health economics : drug-eluting stents -are they worth the money?GERSHLICK, Anthony H; FEARN, Steve.EuroIntervention. 2008, Vol 4, issn 1774-024X, C75-C79, SUPCArticle

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era?COLLINS, Sara D; TORGUSON, Rebecca; KENT, Kenneth M et al.Circulation (New York, N.Y.). 2010, Vol 122, Num 11, pp 1085-1090, issn 0009-7322, 6 p.Article

Current concepts of the interventional treatment of proximal supraaortic vessel stenosisERNEMANN, Ulrike; BENDER, Benjamin; MELMS, Arthur et al.VASA (Bern). 2012, Vol 41, Num 5, pp 313-318, issn 0301-1526, 6 p.Article

Unprotected Left Main Stenting in the Real World Two-Year Outcomes of the French Left Main Taxus RegistryVAQUERIZO, Beatriz; LEFEVRE, Thierry; ZWAHLEN, Marcel et al.Circulation (New York, N.Y.). 2009, Vol 119, Num 17, pp 2349-2356, issn 0009-7322, 8 p.Article

Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomographySHAN LI; YUTANG WANG; LUYUE GAI et al.International journal of cardiology. 2013, Vol 162, Num 3, pp 166-171, issn 0167-5273, 6 p.Article

A nonelutable low-molecular weight heparin stent coating for improved thromboresistanceZHAO, Jonathon; FALOTICO, Robert; NGUYEN, Thai et al.Journal of biomedical materials research. Part B, Applied biomaterials. 2012, Vol 100, Num 5, pp 1274-1282, issn 1552-4973, 9 p.Article

Stent elution rate determines drug deposition and receptor-mediated effectsTZAFRIRI, Abraham R; GROOTHUIS, Adam; SYLVESTER PRICE, G et al.Journal of controlled release. 2012, Vol 161, Num 3, pp 918-926, issn 0168-3659, 9 p.Article